Earnings Call · Q4 FY2024·2025-03-11

Q4 24EPS +71.43%·Rev n/aQ3 24EPS +71.43%·Rev n/aQ2 24EPS -10.53%·Rev n/aQ1 24EPS -15.79%·Rev n/a⚠ consensus missing

Syra Health Corp SYRA

Brett Maas — Director of Investor Relations

Deepika Vuppalanchi — Chair and CEO

Priya Prasad — Chief Financial Officer

+2.9%1d on move date+2.3% vs SPY3d−2.8%5d−5.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SYRA calls or request research access.

More SYRA calls Browse calls Request research access